Drug resistance and tumor recurrence are most of the concerns in clinical practices of GIST.42, 43 To deal with these, our study has revealed a novel tumor promoter, DKK4, which was upregulated by activated Wnt pathway in high‐risk GIST, promoting tumor progression via forming the immune suppressive microenvironment. Here, DKK4 is linked to gastrointestinal stromal tumor.